Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.14 - $4.2 $206,677 - $276,448
65,821 Added 81.28%
146,806 $578,000
Q4 2022

Feb 14, 2023

BUY
$3.53 - $9.5 $285,877 - $769,357
80,985 New
80,985 $320,000
Q3 2020

Nov 16, 2020

SELL
$3.34 - $9.8 $110,888 - $325,360
-33,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.77 - $4.56 $58,764 - $151,392
33,200 New
33,200 $125,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $61.2M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.